Researchers say smoking and diabetes likely have link to brain calcifications.
Computed tomography imaging suggests an increased risk of hippocampal calcifications among people who are older, have diabetes mellitus, or who smoke, according to a study published in the journal Radiology.
Researchers from the Netherlands performed a retrospective cross-sectional study to identify risk factors for hippocampal calcifications and to investigate the association between these calcifications and cognitive function. A total of 1,991 patients (mean age 78 years) participated in the study.
All patients underwent cognitive screening in addition to standard diagnostic work-up and brain CT. “A multiplanar CT scan makes it possible to see the hippocampus in different anatomical planes; for example, from top to bottom, right to left and front to back,” lead author, Esther J.M. de Brouwer, MD, a geriatrician at the University Medical Center in Utrecht, said in a release. “Before multiplanar CT scans, hippocampal calcifications were often mistaken for choroid plexus calcifications. So with multiplanar CT scans, hippocampal calcifications are better distinguished from calcifications in other areas.”
The results showed that most 829 of the 1,991 patients (41.6 percent) had Alzheimer’s disease, 490 (23.6 percent) had mild cognitive impairment, and 332 (16.7 percent) had subjective cognitive impairment. A total of 380 of the 1,991 patients had hippocampal calcifications. Older age, diabetes mellitus, and smoking were associated with their presence, although no association was found between the presence and the severity of hippocampal calcifications and cognitive function.
“We do think that smoking and diabetes are risk factors,” de Brouwer said in the release. “In a recent histopathology study, hippocampal calcifications were found to be a manifestation of vascular disease. It is well known that smoking and diabetes are risk factors for cardiovascular disease. It is, therefore, likely that smoking and diabetes are risk factors for hippocampal calcifications.”
The researchers plan more studies to further examine the possible links.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.